Advanced Practice Provider Perspectives on the Long-Term Safety of Oral Plaque Psoriasis Therapies

Advances practice providers TJ Chao, MPAS, PA-C and Kristine Kucera, PA-C, MPAS, DHS discuss the recent development in the treatment landscape of plaque psoriasis.

Dermatology physician assistants are talking about the evolving role of their profession in taking care of patients with plaque psoriasis.

Physician assistants TJ Chao and Kristine Kucera discuss how the understanding of plaque psoriasis has changed over time and is now considered a systemic disease.

TJ Chao and Kristine Kucera, PA’s go into dept of the recent developments in the systemic oral space of plaque psoriasis.

Dermatology physician assistants review the laboratory and monitoring requirements for TYK2 inhibitors deucravacitinib.

Dermatology physician assistants review the short- and long-term clinical trial data on deucravacitinib.

Advances practice providers in dermatology discuss the safety data on the novel TYK2 inhibitor deucravacitnib.

TJ Chao and Kristine Kucera, PA’s discuss the changing treatment algorithms of plaque psoriasis with the arrival of novel agents such as the TYK2 inhibitors.

Physician assistants TJ Chao and Kristine Kucera share their knowledge on which patients make good candidates for TYK2 inhibitors.

TJ Chao and Kristine Kucera, PA’s share their insights into the patient experience with oral systemic agents for plaque psoriasis.

Expert dermatology physician assistants share how to select the appropriate therapy for your patient with plaque psoriasis in an expanding treatment landscape.